Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.9350
Nov 20 • 3:59 PM ET Dollar change-0.1150 Percentage change(-10.95%)
Aftermarket Close
0.8919
Aftermarket • 7:44 PM ET Dollar change-0.0431 Percentage change(-4.61%)
Index
-
Market Cap
4.97M
Enterprise Value
0.98M
Income
-14.68M
Sales
2.17M
Book/sh
0.11
Cash/sh
0.75
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
17
IPO
Mar 18, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
2.29
P/B
8.90
P/C
1.25
P/FCF
-
EV/EBITDA
-
EV/Sales
0.45
Quick Ratio
1.02
Current Ratio
1.03
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-3.65
EPS next Y
-2.33
EPS next Q
-0.93
EPS this Y
35.75%
EPS next Y
38.11%
EPS next 5Y
31.06%
EPS past 3/5Y
74.91% -125.73%
Sales past 3/5Y
- -
EPS Y/Y TTM
75.46%
Sales Y/Y TTM
145.74%
EPS Q/Q
21.59%
Sales Q/Q
246.99%
Insider Own
3.10%
Insider Trans
7.19%
Inst Own
4.39%
Inst Trans
1.37%
ROA
-140.92%
ROE
-246.11%
ROIC
-3130.92%
Gross Margin
92.61%
Oper. Margin
-692.42%
Profit Margin
-678.24%
SMA20
-45.60%
SMA50
-65.62%
SMA200
-71.27%
Trades
Shs Outstand
5.32M
Shs Float
5.15M
52W High
5.38 -82.62%
52W Low
0.76 22.86%
Volatility
20.28% 14.64%
ATR (14)
0.27
RSI (14)
27.67
Beta
-0.76
Rel Volume
0.70
Avg Volume
194.44K
Volume
135,827
Perf Week
11.52%
Perf Month
-67.19%
Perf Quarter
-70.69%
Perf Half Y
-75.07%
Perf YTD
-61.04%
Perf Year
-69.84%
Perf 3Y
-99.25%
Perf 5Y
-99.96%
Perf 10Y
-
Prev Close
1.05
Price
0.94
Change %
-10.95%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Messinger MichaelChief Financial OfficerNov 16 '26Buy0.852,5002,1245,000Nov 17 06:13 PM
Chung KevinChief Medical OfficerNov 16 '26Buy0.847,8006,58935,821Nov 17 06:13 PM
Messinger MichaelChief Financial OfficerAug 18 '26Buy3.277502,4522,500Aug 19 04:21 PM
Baird Jennifer ADirectorDec 19 '25Buy0.244,20098736,200Dec 22 06:55 PM
Messinger MichaelChief Financial OfficerDec 09 '25Buy0.3514,5005,09817,500Dec 11 06:49 PM
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.
CEOMr. Eric Schlorff
Chief Financial OfficerMr. Michael Messinger CPA
M.D.Colonel Kevin Chung FACP
Co-Founder & Scientific AdvisorDr. H. David Humes M.D.
Vice President of Operations & Product DevelopmentMr. Tom Mullen